The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of pexa-vec (pexastimogene devacirepvec; JX-594), an oncolytic and immunotherapeutic vaccinia virus, in patients with metastatic, refractory renal cell carcinoma (RCC).
 
Seong-Geun Kim
No Relationships to Disclose
 
Hong Koo Ha
No Relationships to Disclose
 
Sung-nam Lim
Speakers' Bureau - Roche
 
Naomi S. De Silva
Stock and Other Ownership Interests - Sillajen
 
Adina Pelusio
Employment - Sillajen
Stock and Other Ownership Interests - Sillajen
Travel, Accommodations, Expenses - Sillajen
 
Jae Hee Mun
Employment - Sillajen
Stock and Other Ownership Interests - Sillajen
 
Richard H. Patt
Employment - RadMD
Stock and Other Ownership Interests - RadMD
Consulting or Advisory Role - Sillajen
Travel, Accommodations, Expenses - Sillajen
 
Caroline J. Breitbach
Employment - Turnstone Bio
Stock and Other Ownership Interests - Turnstone Bio
Consulting or Advisory Role - Jounce Therapeutics; Sillajen
Patents, Royalties, Other Intellectual Property - Inventor of patents held by Sillajen
 
James M. Burke
Employment - Sillajen
Stock and Other Ownership Interests - Sillajen
Consulting or Advisory Role - Sillajen